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Endocrinopathic laminitis encompasses laminitis associated with insulin dysregulation (ID) linked to 1 
an underlying endocrine disease, namely equine metabolic syndrome (EMS) and/or pituitary pars 2 
intermedia dysfunction (PPID), or corticosteroid therapy.  This form of laminitis has been the focus of 3 
a considerable amount of research effort recently and improving ways of making a definitive diagnosis 4 
has been a particular emphasis.  5 
 6 
A diagnosis relies firstly on accurate recognition of the disease by owners, as this then prompts 7 
examination and treatment by a veterinarian and/or farrier. By conducting a cross-sectional study 8 
involving first opinion veterinary practices in the UK, Pollard et al [1] sought to establish whether cases 9 
of owner-suspected laminitis would be confirmed as laminitis by the attending veterinary surgeon. All 10 
owners-suspected laminitis cases were confirmed upon veterinary examination (n=51); however 45% 11 
of cases diagnosed as laminitis by a veterinary surgeon were not recognised as such by owners. This 12 
failure of laminitis recognition by owners highlights the need for evidence-based education to ensure 13 
early disease detection. It also validated inclusion of cases of owner-recognised laminitis in 14 
prospective and retrospective studies. 15 
 16 
It is now universally agreed that insulin dysregulation (ID) is the key, central feature of equine 17 
metabolic syndrome (EMS). In addition, ID is a feature of the subset of animals with pituitary pars 18 
intermedia dysfunction (PPID) that develop laminitis. Equine ID manifests in three forms, namely basal 19 
hyperinsulinaemia, an excessive insulin response to oral carbohydrate and peripheral (tissue) insulin 20 
resistance. Thus, detection of ID is essential to identify animals at an increased risk of endocrinopathic 21 
laminitis. This in turn allows targeted implementation of preventative management strategies to 22 
reduce the risk of disease occurrence. A number of recent publications have sought to determine the 23 




Basal hyperinsulinaemia can be detected by measuring circulating insulin concentrations. However, 26 
the sensitivity of measuring basal insulin concentrations alone to diagnose ID is low and a dynamic 27 
test is preferred. Dynamic tests will either detect an excessive insulin response to oral carbohydrate 28 
or peripheral (tissue) insulin resistance depending on the individual test. The oral glucose test (OGT), 29 
oral sugar test (OST) or a dietary meal challenge test can be used to identify an excessive insulin 30 
response to an oral carbohydrate, whilst the euglycaemia hyperinsulinaemic clamp (EHC), frequently 31 
sampled intravenous glucose tolerance test (FSIGTT), insulin tolerance test (ITT) and combined insulin 32 
glucose test (CGIT) are advocated to detected peripheral insulin resistance. 33 
 34 
The oral glucose test was the first test to be promoted for the detection of ID; however, the 35 
repeatability of the test had not been reported. A recent study by de Laat and Sillence [2] revealed 36 
that the OGT is reasonably repeatable, that a post-glucose sampling point of either 90 or 120 minutes 37 
was acceptable and that an equivalent dose of dietary carbohydrate provided in the form if a 38 
commercial grain mixture (meal challenge test) was a viable and more palatable option for the test. 39 
 40 
More recently, the OST, which uses corn syrup rather than glucose powder to stimulate an insulin 41 
response, has been proposed as a field test to identify ID that manifests as an excessive insulin 42 
response to oral carbohydrate.  It is recommended that the OST be performed after an overnight fast, 43 
but fasting is often impractical in animals kept solely at pasture.  Knowles et al [3] determined that for 44 
dichotomous interpretation (ID or not ID), similar results were obtained using cut-offs of serum insulin 45 
concentration >60 μiu/ml at 60 or 90 min post corn syrup if the test is performed in fasted animals 46 
and >51 μiu/ml at 30 or 60 min post corn syrup in animals maintained at pasture. Thus, fasting is not 47 
essential. However, at any single time point, within-subject coefficients of variation in fasted animals 48 
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were 40% and in animals maintained at pasture were 31%. Therefore, clinicians should beware of the 49 
limits of interpreting changes in absolute OST results. For example, following implementation of a 50 
weight loss program or initiation of a pharmacologic intervention, owing to poor repeatability, small 51 
changes in OST results should not be over-interpreted. 52 
 53 
For the OST, only a dose of 0.1 or 0.15 mL/kg bwt corn syrup has been evaluated previously [4]. Thus, 54 
Jocelyn et al (2018)[5] sought to determine the effect of varying the dose of corn syrup (0.15 vs 0.30 55 
vs 0.45 mL/kg bwt) on the insulin and glucose response to the OST and the test’s ability to distinguish 56 
between ponies with a history of laminitis and those without. The insulin response following 0.15 57 
mL/kg bwt corn syrup was not significantly different from that following 0.3 mL/kg bwt at any time 58 
point. However, the insulin response following 0.45 mL/kg bwt corn syrup significantly differed from 59 
both lower doses at all time points apart from 0 min. The repeatability of the test was fair and there 60 
was no difference between the resulted obtained when the ponies were fasted for 6 hours or 61 
maintained at pasture prior to the test. Using the serum insulin concentration at 60 min, a cut-off 62 
value of 110 iu/ml (measured using a radioimmunoassay) was able to differentiate between 63 
previously laminitic and non-laminitic ponies.  Thus, using a dose of 0.45ml/kg bwt corn syrup 64 
improves the ability of the OST to detect ID that manifests as an excessive insulin response to oral 65 
carbohydrate. 66 
 67 
Whilst both the OGT and OST are advocated as tests suitable for the detection of ID, the two tests 68 
have not been directly compared. Smith et al [6] compared the two tests in horses (n=5) and ponies 69 
(n=8) of unknown insulin sensitivity. Using previously defined criteria of ID, the OGT identified 7/13 70 
animals as ID, whereas the OST identified 5/13 animals as ID. Thus, the OGT and OST agreed in 85% of 71 
equine subjects, but the results of the two tests are not comparable in all cases. Therefore, if repeated 72 
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tests are carried out, care should be taken to ensure that the same test is undertaken each time and 73 
that the two tests are not used interchangeably. 74 
 75 
Finally, Bertin and de Laat [7] reviewed the different tests currently available to diagnose ID that 76 
manifests as peripheral (tissue) insulin resistance. An ideal test would be able to detect horses in the 77 
early stages of ID and would have a strong intrinsic value considering the many environmental and 78 
individual animal factors that have been shown to confound the results of any given test. The authors 79 
concluded that with respect to the possible tests advocated for the diagnosis of peripheral insulin 80 
resistance, fasting blood glucose concentration and proxies derived from glucose and insulin 81 
concentrations are poor diagnostic tests; that the euglycaemia hyperinsulinaemic clamp (EHC) and the 82 
frequently sampled intravenous glucose tolerance test (FSIGTT) were only suitable in the research 83 
setting; that the insulin tolerance test (ITT) is suitable for assessing tissue IR; and that the combined 84 
insulin glucose test (CGIT) requires further validation. In addition, it should be acknowledged that 85 
regardless of the test used, many factors of variation, such as breed, diet, fasting state or season, have 86 
been identified and could potentially confound the results of a specific test. Therefore, careful 87 
interpretation of the results of a given test in each individual situation is required to optimise the 88 
detection of horses at risk of laminitis. 89 
 90 
When undertaking any test to detect any of the manifestations of ID, it should be remembered that a 91 
number of innate (breed, sex, adiposity, genetics) and environmental (diet, exercise) factors affect 92 
insulin dynamics in equids. Jacob et al [8] sought to evaluate the effect of age and dietary carbohydrate 93 
profile on insulin and glucose dynamics. The effect of adaptation to diets containing varying amounts 94 
of starch, fibre and sugar on the glucose and insulin dynamics in two breeds of healthy non obese 95 
adult and aged horses was determined using minimal model analysis of an insulin‐modified frequently 96 
sampled intravenous glucose tolerance test (FSIGTT) as well as the glucose and insulin responses to 97 
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an OST and a dietary meal challenge test. The study found that the effect of age, breed and diet on 98 
glucose and insulin dynamics was variable depending on the assessment. The responses at the tissue 99 
level (FSIGTT) revealed that age influences the acute response insulin to glucose (AIRg), regardless of 100 
diet, whilst adaptation to starch and sugar improves tissue insulin sensitivity (SI) in both adult and 101 
aged horses. In contrast, at the enteral level (assessed using OST), minimal changes in glucose and 102 
insulin parameters due to dietary adaptation were detected. In contrast, the dietary meal challenge 103 
(a single meal of the diet) demonstrated enhanced postprandial hyperinsulinaemia in both adult and 104 
aged horses, following adaptation to both starch‐ and sugar‐rich diets compared to the control and 105 
high fibre diets. Thus, this study highlights the need to consider age and diet when evaluating glucose 106 
and insulin dynamics using certain tests. 107 
 108 
Whilst ID is the central feature of endocrinopathic laminitis, there are other additional risk factors. 109 
Previous studies have evaluated a variety of risk factors in groups of animals after disease occurrence 110 
only and any differences detected may reflect the disease rather than a predisposition. Identifying risk 111 
factors prior to disease occurrence would allow the targeting of preventive management strategies. 112 
Potential risk factors other than ID that require investigation include obesity, inflammatory cytokines 113 
and markers of endothelial dysfunction. Therefore, a prospective cohort study was undertaken to 114 
investigate these risk factors in animals prior to disease occurrence [9]. Various phenotypic and 115 
metabolic markers were evaluated in a cohort of 446 animals with no history of laminitis. After 1, 2 116 
and 3 years, respectively, 18 (4.0%), 30 (6.7%) and 44 (9.9%) animals were reported to have had 117 
laminitis. Plasma adiponectin, and serum basal insulin and insulin post-dexamethasone 118 
concentrations were significantly associated with laminitis occurrence cumulatively after 1, 2 and 3 119 
years. Combinations of these biomarkers did not improve their predictive value and surprisingly, the 120 
development of laminitis was not associated with regional or generalised obesity, hyperleptinaemia 121 
or hypertriglyceridaemia. Thus, risk factors for future laminitis prior to disease occurrence include low 122 
6 
 
plasma adiponectin and high serum basal insulin or insulin post-dexamethasone concentrations. It is 123 
possible that measurement of these in animals could be used to identify animals at an increased risk 124 
of endocrinopathic laminitis before the disease occurs for the first time. Since the radioimmunoassay 125 
used in this prospective study to measure plasma total adiponectin concentrations is no longer valid, 126 
samples from this study were used to validate an immunoturbidimetric assay [10].  127 
 128 
Finally, analysis of plasma adrenocorticotropic hormone (ACTH) concentration aids diagnosis of 129 
pituitary pars intermedia dysfunction (PPID), the second endocrine disease associated with an 130 
increased risk of laminitis. Concentrations are most commonly measured using a validated 131 
chemiluminescent-immunoassay (CI). However, an automated immunofluorescence assay (IF) has 132 
newly been validated in the horse and comparison of the validated chemiluminescent-immunoassay 133 
(CI) and immunofluorescent (IF) assays was limited [11]. Thus, Knowles et al [12] sought to compare 134 
the assays using blood samples collected from a cohort of ponies in autumn (n=99) and spring (n=88) 135 
and additionally to assess assay cross‐reactivity to ACTH fragments. The study found that the results 136 
obtained with the IF assay were proportional to, but lower than, those obtained using the CI assay, 137 
such that the results cannot be used interchangeably. However, using appropriate cut-off values 138 
specific to the assay, agreement for binary classification was good. A different relationship was found 139 
between ACTH concentration results generated by the two methods when measuring concentrations 140 
in samples collected from the same animals in the autumn compared with the spring. A probable 141 
explanation for this finding is cross‐reactivity to or interference by a substance present in equine 142 
plasma at greater concentrations in the autumn than the spring, such as other POMC derived peptides. 143 
This was investigated by the addition of commercially available synthetic ACTH fragments to equine 144 
plasma samples. Cross‐reactivity or interference was demonstrated with both assays, but the most 145 
marked effect was of corticotropin-like intermedia peptide (CLIP) on the CI assay. Thus, the authors 146 
concluded that a naturally occurring autumnal increase in endogenous CLIP production could be 147 
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responsible for the differences between ACTH assays in the present study. Finally, of the 88 ponies 148 
with both spring and autumn samples, 56 (64%) exceeded a published autumn CI threshold (>47 149 
pg/ml), of which 39 (70%) were below the equivalent threshold (<29 pg/ml) the following spring 150 
without treatment. Thus, clinicians should interpret the results of basal ACTH testing with caution and 151 
with reference to clinical signs and in horses that are diagnosed with PPID during the autumn, begin 152 
pergolide treatment and are then retested the following spring, clinicians should be very cautious 153 
before attributing a return of ACTH concentration to reference range to pergolide treatment. 154 
 155 
In conclusion, these nine recent publications have highlighted a number of important advances in 156 
knowledge relating to the diagnosis of endocrinopathic laminitis. Firstly, there is a need for further 157 
evidence-based education to address the under-recognition of laminitis by owners. Secondly, the oral 158 
glucose test (OGT), the OST (OST) using a higher dose of corn syrup (0.45 ml/kg bwt) or a meal 159 
challenge test can all be used to detect an excessive insulin response to carbohydrate, but the tests 160 
do not always agree and have only fair repeatability. Thirdly, the insulin tolerance test (ITT) is the most 161 
suitable test currently available for assessing peripheral (tissue) insulin resistance and that regardless 162 
of the test used to detect ID, many factors of variation, such as breed, diet and age could potentially 163 
confound the results. Fourthly, whilst ID is the central feature of endocrinopathic laminitis, there are 164 
other additional risk factors including low circulating concentrations of the adipokine adiponectin. 165 
Measurement of these could be used to identify animals at an increased risk of endocrinopathic 166 
laminitis before the disease occurs for the first time. Finally, the results obtained using two assay 167 
available for the measurement of ACTH concentrations in animals suspected of having PPID are not 168 
interchangeable; ACTH fragments cross-react with the CI assay; and ACTH concentrations above the 169 
seasonally adjusted reference range in autumn frequently return to normal the following spring and 170 
should be interpreted with caution. All of these papers can be read in full in this special laminitis online 171 
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